RE-BVS – Piemonte Repository

Sfoglia per AUTORE
CARELLA AM
Collezione AOU San Luigi di Orbassano

Items : 5

Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 Y With Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld Study. in Transplantation direct / Transplant Direct. 2023 Feb 22;9(3):e1451. doi: 10.1097/TXD.0000000000001451. eCollection 2023 Mar.

2023
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Proia A; Carluccio P; Borghero C; Pavone V; Skert C; Iori AP; Luppi M; Vacca A; Falcioni S; Onida F; Bassi S; Mazza P; Nozzoli C; Maffini E; Casini M; Chiusolo P; Carella AM; Olivieri A; Terruzzi E; Natale A; De Gobbi M; Bernasconi P; Bramanti S; Grillo G; Giaccone L; Bruno B; Patriarca F; Martino M; Polverelli N; et alii...

GITMO Registry Study on Allogeneic Transplantation in Patients Aged ?60 Years from 2000 to 2017: Improvements and Criticisms. in Transplantation and cellular therapy / Transplant Cell Ther. 2022 Feb;28(2):96.e1-96.e11. doi: 10.1016/j.jtct.2021.11.006. Epub 2021 Nov 21

2022
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Bonifazi F; Mammoliti S; Oldani E; Ciceri F; Russo D; Selleri C; Sacchi N; Borghero C; Proia A; Skert C; Carluccio P; Pavone V; Iori AP; Falcioni S; Luppi M; Mazza P; Bassi S; Onida F; Vacca A; Nozzoli C; Casini M; Carella AM; Terruzzi E; Olivieri A; Chiusolo P; De Gobbi M; Natale A; Bramanti S; Bernasconi P; et alii...

Nilotinib 300 mg twice daily: an academic single-arm study of newly diagnosed chronic phase chronic myeloid leukemia patients. in Haematologica / Haematologica. 2016 Oct;101(10):1200-1207. doi: 10.3324/haematol.2016.144949. Epub 2016 Jul 28.

2016
AOU San Luigi di Orbassano

Castagnetti F; Breccia M; Gugliotta G; Martino B; D'Adda M; Stagno F; Carella AM; Avanzini P; Tiribelli M; Trabacchi E; Visani G; Gobbi M; Salvucci M; Levato L; Binotto G; Capalbo SF; Bochicchio MT; Soverini S; Cavo M; Martinelli G; Alimena G; Pane F; Saglio G; Rosti G; Baccarani M;

A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma. in Leukemia / Leukemia. 2016 Jun;30(6):1320-6. doi: 10.1038/leu.2016.36. Epub 2016 Feb 22.

2016
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Palumbo A; Sonneveld P; Offidani M; Boccadoro M; Musolino C; De Paoli L; Conticello C; Nozzoli C; Aghemo E; Derudas D; Genuardi M; Guglielmelli T; Carella AM; Ponticelli E; Spada S; Vincelli ID; De Rosa L; Omedé P; Morabito F; Montefusco V; Passera R; Benevolo G; Liberati AM; Falcone AP; Caravita T; Villani O; Oliva S; Petrucci MT; Bringhen S; et alii...

Rotation of nilotinib and imatinib for first-line treatment of chronic phase chronic myeloid leukemia. in American journal of hematology / Am J Hematol. 2016 Jun;91(6):617-22. doi: 10.1002/ajh.24362. Epub 2016 Apr 24.

2016
AOU San Luigi di Orbassano

Gugliotta G; Castagnetti F; Breccia M; Gozzini A; Usala E; Carella AM; Rege-Cambrin G; Martino B; Abruzzese E; Albano F; Stagno F; Luciano L; D'Adda M; Bocchia M; Cavazzini F; Tiribelli M; Lunghi M; Pia Falcone A; Musolino C; Levato L; Venturi C; Soverini S; Cavo M; Alimena G; Pane F; Martinelli G; Saglio G; Rosti G; Baccarani M; et alii...